论文部分内容阅读
肺炎支原体是可导致人类支原体肺炎的一种病原微生物,是儿童急性下呼吸道感染的主要病原体,非流行年份可占到小儿肺炎病因的11%~22%,在流行年份可达到30%以上,支原体肺炎全年均可发病,秋冬季为高峰。由于抗生素的滥用,国内外出现了多重耐药性的菌株,给临床治疗带来了极大的困难[1]。本文报道采用药敏试剂盒对肺炎支原体菌株进行药物敏感试验,观察支原体的耐药情况,为临床治疗肺炎支原体感染者提供参考。
Mycoplasma pneumoniae is a pathogenic microorganism that can cause human mycoplasma pneumonia and is the main pathogen of acute lower respiratory tract infection in children. Non-endemic years can account for 11% -22% of the causes of pneumonia in children and 30% or more in epidemic years. Mycoplasma Pneumonia can be disease throughout the year, autumn and winter as the peak. Due to the abuse of antibiotics, multi-drug resistant strains have appeared at home and abroad, which brings great difficulties to clinical treatment [1]. This article reports the use of drug sensitivity kit of Mycoplasma pneumoniae strains susceptibility testing to observe the drug resistance of Mycoplasma for the clinical treatment of Mycoplasma pneumoniae infection provide a reference.